Cargando…
Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure
INTRODUCTION: Hydroxychloroquine (HCQ) emerged early in the course of the coronavirus disease 2019 (COVID-19) pandemic as a possible drug with potential therapeutic and prophylactic benefits. It was quickly adopted in China, Europe, and the USA. We systematically reviewed the existing clinical evide...
Autores principales: | Rakedzon, Stav, Khoury, Yara, Rozenberg, Gilad, Neuberger, Ami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rambam Health Care Campus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426548/ https://www.ncbi.nlm.nih.gov/pubmed/32792041 http://dx.doi.org/10.5041/RMMJ.10416 |
Ejemplares similares
-
Impact of the coronavirus disease 2019 pandemic on surgical research and lessons for the future
por: Keswani, Sundeep G., et al.
Publicado: (2021) -
Elective shoulder surgery during the coronavirus disease 2019 pandemic in Germany: the patients' perspective
por: Bockmann, Benjamin, et al.
Publicado: (2021) -
General surgery chief residents’ perspective on surgical education during the coronavirus disease 2019 (COVID-19) pandemic
por: Zheng, Jian, et al.
Publicado: (2020) -
Is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present intraperitoneally in patients with coronavirus disease 2019 (COVID-19) infection undergoing emergency operations?
por: Seeliger, Barbara, et al.
Publicado: (2020) -
Treatment of COVID-19 Patients in Italy: A Physician’s Experience and Insights
por: Gilad, Vered, et al.
Publicado: (2020)